176 related articles for article (PubMed ID: 2420387)
1. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
Letarte M; Addis J; Iturbe S; Petsche D
Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
[TBL] [Abstract][Full Text] [Related]
2. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Horibe K; Knowles RW; Dupont B
Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
[TBL] [Abstract][Full Text] [Related]
3. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
[TBL] [Abstract][Full Text] [Related]
5. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.
Brodsky FM
Immunogenetics; 1984; 19(3):179-94. PubMed ID: 6200433
[TBL] [Abstract][Full Text] [Related]
6. Divergent and invariant HLA class II beta chain isoelectric points.
Bontrop R; van Miltenburg R; Koning F; Gerrets R; Hyland C; Giphart M
Hum Immunol; 1986 May; 16(1):38-51. PubMed ID: 2423486
[TBL] [Abstract][Full Text] [Related]
7. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
8. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
Falk JA; Lewis WH; Letarte M
Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
10. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
Bismuth G; Gouy H; Karr RW; Debré P
Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
[TBL] [Abstract][Full Text] [Related]
11. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
Nuñez G; Stastny P
Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.
Goyert SM; Silver J
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5719-23. PubMed ID: 6193521
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
14. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
Johnson JP; Wank R
Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
[TBL] [Abstract][Full Text] [Related]
15. Epitope analysis with monoclonal antibodies directed against class II molecules subdivides HLA-DR2, DR3 and DR4: correlations with cellularly defined Dw specificities.
Johnson JP; Nordwig H; Wank R
Tissue Antigens; 1987 Jan; 29(1):26-33. PubMed ID: 2438806
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the HLA-DRw9 antigen using two-dimensional gel electrophoresis and alloantisera.
Yabe T; Suzuki M; Mukai R; Satake M; Juji T; Hamaguchi H
Jinrui Idengaku Zasshi; 1984 Mar; 29(1):17-25. PubMed ID: 6205188
[No Abstract] [Full Text] [Related]
17. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
Karr RW; Hsu SH; Bias WB
Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
[TBL] [Abstract][Full Text] [Related]
18. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
19. Evidence that celiac disease is primarily associated with a DC locus allelic specificity.
Tosi R; Vismara D; Tanigaki N; Ferrara GB; Cicimarra F; Buffolano W; Follo D; Auricchio S
Clin Immunol Immunopathol; 1983 Sep; 28(3):395-404. PubMed ID: 6192959
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR7-specific monoclonal antibodies and a chimpanzee anti-DR7 serum detect different epitopes on the same molecule.
Radka SF; Amos DB; Quackenbush LJ; Cresswell P
Immunogenetics; 1984; 19(1):63-76. PubMed ID: 6198273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
